Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update
Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update GlobeNewswire May 13, 2025 – Announced preclinical data demonstrating the bioequivalence of RT-114, a bispecific GLP-1/GLP-2 receptor agonist (PG-102), delivered orally via the RaniPill(R) capsule, to subcutaneous administration of PG-102 – – Phase 1 study for RT-114 for the treatment of obesity expected to […]